z-logo
Premium
Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose–volume analysis
Author(s) -
Mazzola Rosario,
Ricchetti Francesco,
Fersino Sergio,
Fiorentino Alba,
Giaj Levra Niccolò,
Di Paola Gioacchino,
Ruggieri Ruggero,
Alongi Filippo
Publication year - 2016
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.24106
Subject(s) - mucositis , medicine , dysphagia , radiation therapy , oral mucosa , cancer , oral cavity , chemotherapy , head and neck cancer , gastroenterology , nuclear medicine , surgery , pathology , dentistry
Background The purpose of this study was to assess predictors of mucositis in oropharyngeal and oral cavity cancer after definitive or adjuvant volumetric modulated arc radiotherapy (VMAT) +/− chemotherapy. Methods Fifty patients were evaluated. Statistical analysis was performed for the following parameters as potential predictors of mucositis ≥ G2: total oral mucosa and oral mucosa minus target high‐low radiation dose regions (planning target volumes [PTVs]), mean dose (D mean ), maximum dose (D max ), chemotherapy, weight loss, and dysphagia. Results Mucositis ≥ G2 was found to be statistically related to chemotherapy, weight loss, dysphagia ≥ G2, total oral mucosa D mean ≥50 Gy and D max ≥65 Gy, V 45 Gy >40%, V 50 Gy >30%, and V 55 Gy >20% of the oral mucosa minus target PTVs. A ratio between total oral mucosa and oral mucosa minus target PTVs >2.5 is related to G3 mucositis ( p = .03). Conclusion New parameters were found as predictors of moderate‐severe mucositis. © 2015 Wiley Periodicals, Inc. Head Neck 38 : E815–E819, 2016

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom